Jonathan Schelfhout

61 papers receiving 789 citations

Jonathan Schelfhout's Hit Papers

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials 2022 · 178 citations
1780+1+2Years since publication50100150

Peers

Jonathan Schelfhout
Comparison fields: 5 of 74
  • Emergency Medical Services 227
  • Gastroenterology 142
  • Physiology 559
  • Pulmonary and Respiratory Medicine 654
  • Speech and Hearing 55
Replace Kristina Biekšienė with:
Kristina Biekšienė Lithuania
Mirjam J.G. van Manen Netherlands
Cécile Lambe France
Yewon Kang South Korea
Shafik Sidani United States
Catherine M. Bonuccelli United States
Grace Oscullo Spain
Fehmi Ateşž Türkiye
G.M. Shaw New Zealand
P.-O. Stotzer Sweden
Jonathan Schelfhout relative to Kristina Biekšienė Lithuania Kristina Biekšienė's profile →
Citations per field
00.5×1.5×2.0×
Kristina Biekšienė · 1×
Citations per year

Countries citing papers authored by Jonathan Schelfhout

Since Specialization
Citations

This map shows the geographic impact of Jonathan Schelfhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Schelfhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Schelfhout more than expected).

Fields of papers citing papers by Jonathan Schelfhout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Schelfhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Schelfhout. The network helps show where Jonathan Schelfhout may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Schelfhout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Schelfhout Line = papers co-authored together Jonathan Schelfhout links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
Hit paper breakdown →
2022178
2 202165
3 202165
4 202143
5 202236
6 202128
7 202028
8 202027
9 202321
10 202020
11 202319
12 201919
13 202219
14 202216
15 202116
16 202015
17 202214
18 202013
19 202113
20 202212

About Jonathan Schelfhout

Jonathan Schelfhout is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Emergency Medical Services, Gastroenterology and Epidemiology, having authored 64 papers that have together received 806 indexed citations. Recurring topics across this work include Respiratory and Cough-Related Research (52 papers), Asthma and respiratory diseases (35 papers), Voice and Speech Disorders (14 papers), Pediatric health and respiratory diseases (14 papers), Gastroesophageal reflux and treatments (11 papers), Dysphagia Assessment and Management (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Polyomavirus and related diseases (3 papers). The work is most often cited by research in Emergency Medical Services (227 citations), Gastroenterology (142 citations), Physiology (559 citations), Pulmonary and Respiratory Medicine (654 citations) and Speech and Hearing (55 citations). Jonathan Schelfhout has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Allison Martin Nguyen, Surinder S. Birring, David Muccino, Carmen La Rosa, Peter V. Dicpinigaitis, Lorcan McGarvey, Alyn H. Morice, John A. Smith, Margaret Vernon and Anjela Tzontcheva. Their work appears in journals such as Lung, Journal of Allergy and Clinical Immunology, BMC Pulmonary Medicine, Therapeutic Advances in Respiratory Disease and ERJ Open Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact